D. Mark McClung
Executive Vice President, Chief Operating Officer
COO
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Sangamo Therapeutics, Inc (SGMOQ) | Former Executive Vice President, Chief Operating Officer | $513,240 | $1,116,596 |
| 2022 | Sangamo Therapeutics, Inc (SGMOQ) | Former Executive Vice President, Chief Operating Officer | $493,500 | $1,674,251 |
| 2021 | Sangamo Therapeutics, Inc (SGMOQ) | Former Executive Vice President, Chief Operating Officer | $427,673 | $1,657,289 |
| 2020 | Sangamo Therapeutics, Inc (SGMOQ) | Executive Vice President, Chief Operating Officer | $276,667 | $2,671,226 |
Earnings-call appearances
-
Sangamo Therapeutics, Inc Q3 FY2023 Earnings Call2023-11-01
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q2 FY2023 Earnings Call2023-08-08
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q1 FY2023 Earnings Call2023-04-26
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q3 FY2022 Earnings Call2022-11-03
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q2 FY2022 Earnings Call2022-08-04
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q1 FY2022 Earnings Call2022-05-05
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q4 FY2020 Earnings Call2021-02-24
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q3 FY2020 Earnings Call2020-11-04
Sangamo Therapeutics, Inc (SGMOQ)